BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38071043)

  • 21. [Distribution of Type 9 T Helper Cells and Expression of Transcriptional Factors in Acute Myeloid Leukemia].
    Yang H; Qiu HR; Wang R; Guo R; Wang Y; Wang H; Wu YJ; Zhang JF; Fan L; Qian SX; Xu W; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1295-1299. PubMed ID: 29070098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The autocrine motility factor receptor is overexpressed on the surface of B cells in Binet C chronic lymphocytic leukemia.
    Grund S; Olsson B; Jernås M; Jacobsson S; Swolin B; Nabi IR; Carlsson L; Wadenvik H
    Med Oncol; 2011 Dec; 28(4):1542-8. PubMed ID: 20574759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patients.
    Monserrat J; Sánchez MÁ; de Paz R; Díaz D; Mur S; Reyes E; Prieto A; de la Hera A; Martínez-A C; Alvarez-Mon M
    Cytometry B Clin Cytom; 2014 Jan; 86(1):32-43. PubMed ID: 24166938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p-STAT6, PU.1, and NF-κB are involved in allergen-induced late-phase airway inflammation in asthma patients.
    Hoppenot D; Malakauskas K; Lavinskiene S; Sakalauskas R
    BMC Pulm Med; 2015 Oct; 15():122. PubMed ID: 26466682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-10-1082A>G (rs1800896) Single Nucleotide Polymorphism is Not a Risk Factor of Chronic Lymphocytic Leukemia in Sudanese Population.
    Basabaeen AA; Abdelgader EA; Ahmed EB; Abdelateif NM; Osman Abdelrahim S; Sharif OM; Altayeb OA; Fadul EA; Osman Ibrahim I
    Asian Pac J Cancer Prev; 2022 Sep; 23(9):3229-3235. PubMed ID: 36172689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.
    Bulian P; Rossi D; Forconi F; Del Poeta G; Bertoni F; Zucca E; Montillo M; Pozzato G; D'Arena G; Efremov DG; Marasca R; Lauria F; Gaidano G; Gattei V; Laurenti L
    J Transl Med; 2012 Jan; 10():18. PubMed ID: 22289136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis.
    Aguilar-Santelises M; Loftenius A; Ljungh C; Svenson SB; Andersson B; Mellstedt H; Jondal M
    Leuk Res; 1992; 16(6-7):607-13. PubMed ID: 1386130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral blood Th9 cells and eosinophil apoptosis in asthma patients.
    Hoppenot D; Malakauskas K; Lavinskienė S; Bajoriūnienė I; Kalinauskaitė V; Sakalauskas R
    Medicina (Kaunas); 2015; 51(1):10-7. PubMed ID: 25744770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fluorescence in Situ Hybridization for Detecting Molecular Cytogenetic Abnormalities of Chronic Lymphocytic Leukemia].
    Zhang HY; Yang YL; Zhao Q; Zhang J; Bai H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1474-1479. PubMed ID: 33067940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [TIM-3/galectin-9 is involved in negative regulation of T cells in patients with chronic lymphocytic leukemia].
    Xierenguli A; Zeng X; Pang N; Zhagn R; Ma J; Zhao Y; Qu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1021-1025. PubMed ID: 33210597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of peripheral CD4+ CXCR5+ T cells with chronic lymphocytic leukemia.
    Cha Z; Zang Y; Guo H; Rechlic JR; Olasnova LM; Gu H; Tu X; Song H; Qian B
    Tumour Biol; 2013 Dec; 34(6):3579-85. PubMed ID: 23807677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [PD-1/PD-L1 expression and its implications in patients with chronic lymphocytic leukemia].
    Li JH; Pang NN; Zhang ZH; Zhang R; Chen G; Qu JH
    Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):198-203. PubMed ID: 28395442
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum Interleukin 6 (IL -6) as Prognostic Marker in Egyptian CLL patients.
    Hassan EA; Abdelhady EA; Abdelsamee HF; Sallam MTH; El-Razzaz MK
    Int J Hematol Oncol Stem Cell Res; 2024 Apr; 18(2):140-146. PubMed ID: 38868807
    [No Abstract]   [Full Text] [Related]  

  • 35. [Role of Th9, Th17, Treg Cells levels and IL-9, IL-17 and TGF-β Expression in Peripheral Blood of Patients with ITP in Pathogenesis of ITP].
    Zhou ZJ; Zhang YS; Liang CX; Yang ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):180-184. PubMed ID: 30738467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated expression of interleukin 16 in chronic lymphocytic leukemia is associated with disease burden and abnormal immune microenvironment.
    Wu X; Thisdelle J; Hou S; Fajardo-Despaigne JE; Gibson SB; Johnston JB; Dawe DE; Banerji V; Marshall AJ
    Leuk Res; 2023 Aug; 131():107315. PubMed ID: 37263073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of bone-marrow pattern and immunophenotypic score in B-chronic lymphocytic leukemia at diagnosis.
    Jahic A; Iljazovic E; Arnautovic-Custovic A; Halilbasic A; Simendic V; Zabic A
    Med Arh; 2011; 65(3):132-6. PubMed ID: 21776871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diminished production of interleukin-6 in chronic lymphocytic leukaemia (B-CLL) cells from patients at advanced stages of disease. Tampere CLL Group.
    Hulkkonen J; Vilpo J; Vilpo L; Hurme M
    Br J Haematol; 1998 Mar; 100(3):478-83. PubMed ID: 9504629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of IL-9 in Peripheral Lymphocytes of Rheumatoid Arthritis Patients and Healthy Donors by Th17-Inducing Cytokine Conditions.
    Heim J; Almanzar G; Schmalzing M; Gernert M; Tony HP; Prelog M
    Front Immunol; 2021; 12():668095. PubMed ID: 33995403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-35 Suppresses Interleukin-9-Secreting CD4
    Zhang Q; Yang L; Liu S; Zhang M; Jin Z
    Front Immunol; 2021; 12():645835. PubMed ID: 34177894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.